Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Portland OR, Eugene OR, Walnut Creek CA, Campbell CA,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase 2, Recruiting

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

for
Diabetic Macular Edema
Location: Portland OR, Eugene OR, Sacramento CA, Walnut Creek CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07553429

Phase 1, Phase 2, Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Portland OR, Eugene OR, Spokane WA, Sacramento CA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase 3, Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Portland OR, Seattle WA, Edmonton, Irving TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase 1, Phase 2, Recruiting

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

for
Heart Failure NYHA Class II, Heart Failure NYHA Class III,
Location: Portland OR, Everett WA, San Francisco CA,
Sponsor: Endotronix, Inc.

Sex: All

Age: 18+

Code: NCT05934487

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for
Endometrial Cancer
Location: Portland OR, Seattle WA, Victoria, Vancouver, Kelowna,
Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase 2, Recruiting

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Portland OR, Issaquah WA, Seattle WA, Edmonds WA,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT06388018

Phase 2, Recruiting

Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)

for
Neurodevelopmental Abnormality
Location: Portland OR, Salt Lake City UT, Edmonton,
Sponsor: Sharp HealthCare

Sex: All

Age: 1 - 3

Code: NCT03476980

Recruiting

Impella RP Flex with Smart Assist

for
Right Ventricular (RV) Dysfunction
Location: Portland OR, Puyallup WA, Spokane WA, Missoula MT,
Sponsor: Abiomed Inc.

Sex: All

Age: 0+

Code: NCT06637644

Recruiting

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Portland OR, Seattle WA, Palo Alto CA,
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT05911568

Recruiting

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

for
In-Stent Restenosis, Cardiovascular Diseases,
Location: Portland OR, Los Angeles CA, Gilbert AZ, Minneapolis MN,
Sponsor: Concept Medical Inc.

Sex: All

Age: 18 - 70+

Code: NCT05908331

Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

for
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms,
Location: Portland OR, Sacramento CA, San Francisco CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07218380

Phase 3, Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for
Astrocytoma, IDH-Mutant, Grade 3
Location: Portland OR, Seattle WA, Roseville CA, Sacramento CA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 12+

Code: NCT07215910

Phase 3, Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

for
Metastatic Castration-Resistant Prostate Carcinoma,
Location: Portland OR, Seattle WA, Edmonds WA, Post Falls ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT07200830

Phase 3, Recruiting

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

for
Coronary Artery Disease,
Location: Portland OR, Sacramento CA, Murray UT, Thousand Oaks CA,
Sponsor: Supira Medical

Sex: All

Age: 18 - 70+

Code: NCT07296744

Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

for
Hepatocellular Carcinoma (HCC)
Location: Portland OR, Duarte CA, Nashville TN, Hackensack NJ,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07291076

Phase 1, Phase 2, Recruiting

FORWARD CAD IDE Study

for
Coronary Arterial Disease (CAD)
Location: Portland OR, Seattle WA, Bellevue WA, San Francisco CA,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT06662500

Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Portland OR, Vancouver, Sacramento CA, San Francisco CA,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase 3, Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for
Non-Small Cell Lung Cancer
Location: Portland OR, Reno NV, Calgary, Orange CA, Irvine CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07100080

Phase 2, Phase 3, Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

for
Breast Neoplasms
Location: Portland OR, Los Angeles CA, Loveland CO, Greeley CO,
Sponsor: Eli Lilly and Company

Sex: Female

Age: 18+

Code: NCT07287098

Phase 2, Recruiting